中文 | English
Return
Total: 1665 , 1/167
Show Home Prev Next End page: GO
Author:(Wang-zhen CHEN)

1.Therapeutic Observation of Cupping plus Chinese Medicinal Fumigation for Chronic Obstructive Pulmonary Disease Due to Phlegm-heat Obstructing the Lung

Shengqian CHEN ; Zhen WANG

Shanghai Journal of Acupuncture and Moxibustion 2016;35(6):650-652

2.Therapeutic Evaluation of Tuina and Hyperbaric Oxygen for Prolapse of Lumbar Intervertebral Disc

Wei CHEN ; Jianxiong WANG ; Zhen WANG

Journal of Acupuncture and Tuina Science 2011;09(1):58-61

3.The mTORC1 signaling network underlying the pathogenesis and treatment of depression:new insights into rapid-acting antidepressant therapies

Ting ZENG ; Zhen-Zhen WANG ; Nai-Hong CHEN

Chinese Journal of Pharmacology and Toxicology 2018;32(4):331-331

5.Experimental Study on Lung Cancer Model Induced by Bronchial Perfusion of 3, 4-benzopyrene in Pigs

Jinrun CHEN ; Limin YANG ; Zhen ZHANG ; Wei WANG ; Zhen ZHAO

Journal of Kunming Medical University 2013;(12):15-18

6.Association of depression with dietary fatty acids and the progress of mechanism research

Ning-ning ZHANG ; Zhen-zhen WANG ; Nai-hong CHEN

Acta Pharmaceutica Sinica 2021;56(4):906-912

7.Concurrent chemoradiotherapy and adjuvant chemotherapy for rectal cancer

Jie CHEN ; Zhen TAO ; Ping WANG

Journal of International Oncology 2012;(11):864-866

8.Rheohepatogram in evaluation of liver blood perfusion in portal hypertensive patients undergoing pericardial devascularization

Libo CHEN ; Guobin WANG ; Zhen YANG

Chinese Journal of General Surgery 2000;0(12):-

9.Effects of free fatty acids on apoptosis and migration of human breast cancer cells

Chen WANG ; Junlong ZHUANG ; Zhen BIAN

Chinese Journal of Clinical Nutrition 2011;19(5):307-311

10.Down regulation of miR-33a is involved in gemcitabine chemoresistance in human pancreatic cancer

Chen LIANG ; Zhen WANG ; Yingyi LI

China Oncology 2015;(2):87-94

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1665 , 1/167 Show Home Prev Next End page: GO